Monopar Therapeutics Inc. · NASDAQ:MNPR
Robinson Chandler sold 29,056 Monopar Therapeutics Inc. shares (Form 4)
Traded Sep 24, 2026 · Filed Sep 28, 2026
On Sep 24, 2026, Robinson Chandler (Director, Chief Executive Officer) sold 29,056 Monopar Therapeutics Inc. shares at an average US$88.00 for US$2.56M under a trading plan, leaving 99,267 shares. Filed Sep 28, 2026 (Form 4).
- Sold
- 29,056 shares
- Price
- US$88.00 average (US$87.15 to US$89.79)
- Value
- US$2.56M
- Holding after
- 99,267 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | Option exercise | 14,056 | US$30.00 | 113,323 | Direct |
| Sep 24, 2026 | Common Stock | Option exercise | 15,000 | US$14.00 | 128,323 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 10,450 | US$87.15 | 117,873 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 9,638 | US$87.96 | 108,235 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 8,368 | US$88.97 | 99,867 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 600 | US$89.79 | 99,267 | Direct |
Source
Related
- Monopar Therapeutics Inc.
- Robinson Chandler
- Monopar Therapeutics Inc. shareholders
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026
- Form 4 · Robinson Chandler · Jul 2, 2026
- Form 4 · Robinson Chandler · Apr 2, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4/A · Tsuchimoto Kim R · Aug 28, 2026
- Form 4/A · Anderson Raymond · Aug 28, 2026